在型肝炎病毒流行地区的乙型肝炎患病率:一项涉及泰国型肝炎消除的基于人口的研究
Nawarat Posuwan1,2, Rujipat Wasitthankasem3, Napaporn Pimsing4
1Center of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Journal of virus eradication
|January 6, 2025
概括
泰国Phetchabun的乙型肝炎 (HBV) 患病率因年龄和行为而异. 年轻人患病率较低,而老年人患HBV感染风险较高,这凸显了有针对性的消除策略的必要性.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 传染性疾病 传染性疾病
背景情况:
- 慢性乙型肝炎 (HBV) 和C型肝炎 (HCV) 在泰国造成严重的健康负担.
- 费查本省是肝炎消除工作的关键地区,因为其HCV流行率很高.
研究的目的:
- 为了评估B型肝炎病毒 (HBV) 感染在Phetchabun省的流行率.
- 为了确定与不同年龄组的HBV传播相关的风险因素.
主要方法:
- 在2015年,2017年和2018年进行的三个横截面人口研究.
- 使用ARCHITECT测定方法分析HBsAg的血样本.
- 从高endemic和全省范围的环境中从成年人和年轻成年人中收集的数据.
主要成果:
- 在年轻成年人中,HBsAg血清阳性为3.1%,在成年人中为5.9%-6.3%.
- 风险因素包括年龄,教育,注射药物使用和MSM行为.
- 在泰国扩大疫苗接种计划 (EPI) 之后出生的个人显示HBV率<1%.
结论:
- 在Phetchabun,HBV的患病率在不同年龄组之间有显著差异.
- 不同的传播模式受到社会和行为因素的影响.
- 这些发现对于在泰国制定向性肝炎消除策略至关重要.
相关概念视频
Pulmonary Tuberculosis V
1.0K
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
1.0K
Hepatic Drug Excretion: Enterohepatic Cycling
3.7K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
3.7K
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
400
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
400
Infectious Diseases and Their Occurrence
97
Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable...
97
Hepatitis
99
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
99
Viral Hepatitis I: Introduction
28
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion...
28


